Shared features in the pathobiology of babesiosis and malaria

Trends in Parasitology

Volumn 23, Issue 12, 2007, Pages 605-610

  Krause, Peter J ^a   Daily, Johanna ^b   Telford, Sam R ^c   Vannier, Edouard ^d   Lantos, Paul ^b   Spielman, Andrew ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c TUFTS UNIVERSITY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BABESIOSIS; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE PRODUCTION; DISEASE COURSE; ERYTHROCYTE ADHESIVENESS; HUMAN; KIDNEY INFECTION; LIVESTOCK; LUNG INFECTION; MALARIA; NONHUMAN; PATHOGENESIS; PATHOLOGY; PLASMODIUM FALCIPARUM; REVIEW;

ANIMALS; BABESIOSIS; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; ERYTHROCYTES; HUMANS; KIDNEY DISEASES; LUNG DISEASES, PARASITIC; MALARIA, FALCIPARUM; SEVERITY OF ILLNESS INDEX;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 36349036451     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.09.005     Document Type: Review

References (73)

1. In: Lederberg J., et al. (Ed). Emerging Infections: Microbial Threats to Health in the United States (1992), National Academy Press
2. Gorenflot A., et al. Human babesiosis. Ann. Trop. Med. Parasitol. 92 (1998) 489-501
3. Homer M.J., et al. Babesiosis. Clin. Microbiol. Rev. 13 (2000) 451-469
4. Boutlis C.S., et al. Malaria tolerance - for whom the cell tolls?. Trends Parasitol. 22 (2006) 371-377
5. Krause P.J., et al. Persistent parasitemia following acute babesiosis. N. Engl. J. Med. 339 (1998) 160-165
6. Taylor T.E., and Strickland G.T. Malaria. In: Strickland G.T. (Ed). Hunter's Tropical Medicine and Emerging Infectious Diseases. 8th edn (2000), W.B. Saunders 614-643
7. Nsobya S.L., et al. Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children. J. Infect. Dis. 189 (2004) 2220-2226
8. Alves F.P., et al. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am. J. Trop. Med. Hyg. 66 (2002) 639-640
9. Coura J.R., et al. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection- a review. Mem. Inst. Oswaldo Cruz 101 (2006) 229-237
10. Krause P.J., et al. Increasing health burden of human babesiosis in endemic sites. Am. J. Trop. Med. Hyg. 68 (2003) 431-436
11. Curnow J.A. In vitro agglutination of bovine erythrocytes infected with Babesia argentina. Nature 217 (1968) 267-268
12. Brown K.N., and Brown I.N. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature 208 (1965) 1286-1288
13. Barnwell J.W., et al. Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria. Infect. Immun. 40 (1983) 985-994
14. Curnow J.A. Studies on antigenic changes and strain differences in Babesia argentina infections. Aust. Vet. J. 49 (1973) 279-283
15. Allred D.R. Babesiosis: persistence in the face of adversity. Trends Parasitol. 19 (2003) 51-55
16. Allred D.R., and Al-Khedery B. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal. Mol. Biochem. Parasitol. 134 (2004) 27-35
17. Al-Khedery B., and Allred D.R. Antigenic variation in Babesia bovis occurs through segmental gene conversion of the ves multigene family, within a bidirectional locus of active transcription. Mol. Microbiol. 59 (2006) 402-414
18. Kyes S., et al. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol. 55 (2001) 673-707
19. Montgomery J., et al. Genetic analysis of circulating and sequestered populations of Plasmodium falciparum in fatal pediatric malaria. J. Infect. Dis. 194 (2006) 115-122
20. Goff W.L., et al. The age-related immunity in cattle to Babesia bovis infection involves the rapid induction of interleukin-12, interferon-gamma and inducible nitric oxide synthatase mRNA expression in the spleen. Parasite Immunol. 23 (2001) 463-471
21. Wittner M., et al. Successful chemotherapy of transfusion babesiosis. Ann. Intern. Med. 96 (1982) 601-604
22. Fitzpatrick J.E.P., et al. Further details of third recorded case of Redwater (Babesiosis) in man. BMJ 4 (1969) 770-772
23. Krause P.J., et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. J. Am. Med. Assoc. 275 (1996) 1657-1660
24. Clark I.A., et al. Protection of mice against Babesia and Plasmodium with BCG. Nature 259 (1976) 309-311
25. Clark I.A., et al. Possible importance of macrophage-derived mediators in acute malaria. Infect. Immun. 32 (1981) 1058-1066
26. Clark I.A., et al. Pathogenesis of malaria and clinically similar conditions. Clin. Microbiol. Rev. 17 (2004) 509-539
27. Creagan E.T., et al. A phase I clinical trial of recombinant human tumor necrosis factor. Cancer 62 (1988) 2467-2471
28. Shaio M.F., and Lin P.R. A case study of cytokine profiles in acute human babesiosis. Am. J. Trop. Med. Hyg. 58 (1998) 335-337
29. Clark I.A., et al. Human malarial disease: a consequence of inflammatory cytokine release. Malar. J. 5 (2006) 85
30. Shoda L.K., et al. Babesia bovis-stimulated macrophages express interleukin-1beta, interleukin-12, tumor necrosis factor alpha, and nitric oxide and inhibit parasite replication in vitro. Infect. Immun. 68 (2000) 5139-5145
31. Taiwo B., et al. Can tumor necrosis factor α blockade predispose to severe babesiosis?. Arthritis Rheum. 57 (2007) 179-181
32. Kwiatkowski D., et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336 (1990) 1201-1204
33. Karunaweera N.D., et al. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin. Exp. Immunol. 88 (1992) 499-505
34. Hemmer R.M., et al. Up-regulation of tumor necrosis factor-alpha and interferon-gamma expression in the spleen and lungs of mice infected with the human Babesia isolate WA1. Parasitol. Res. 86 (2000) 121-128
35. Hemmer R.M., et al. Role of T cells and cytokines in fatal and resolving experimental babesiosis: protection in TNFRp55-/- mice infected with the human Babesia WA1 parasite. J. Parasitol. 86 (2000) 736-742
36. Pruss A., et al. Immune hemolysis-serological and clinical aspects. Clin. Exp. Med. 3 (2003) 55-64
37. Parrodi F., et al. In vitro adherence of erythrocytes infected with Babesia bigemina and Babesia rodhaini to thrombospondin. Int. J. Parasitol. 20 (1990) 899-903
38. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster (2000). Trans. R. Soc. Trop. Med. Hyg. 94, S1-S90
39. Hatcher J.C., et al. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin. Infect. Dis. 32 (2001) 1117-1125
40. Persing D.H., et al. Infection with a Babesia-like organism in northern California. N. Engl. J. Med. 332 (1995) 298-303
41. Brown W.C., et al. Immune control of Babesia bovis infection. Vet. Parasitol. 138 (2006) 75-87
42. Krause, P.J. et al. (2007) Persistent and relapsing Babesiosis in immunocompromised patients. Clin. Infect. Dis. (in press)
43. Clark I.A., and Cowden W.B. The pathophysiology of falciparum malaria. Pharmacol. Ther. 99 (2003) 221-260
44. Dao A.H., and Eberhard M.L. Pathology of acute fatal babesiosis in hamsters experimentally infected with the WA-1 strain of Babesia. Lab. Invest. 74 (1996) 853-859
45. Wozniak E.J., et al. Comparative pathogenesis of human WA-1 and Babesia microti isolates in a Syrian hamster model. Lab. Anim. Sci. 46 (1996) 507-515
46. Hemmer R.M., et al. Endothelial cell changes are associated with pulmonary edema and respiratory distress in mice infected with the WA1 human Babesia parasite. J. Parasitol. 85 (1999) 479-489
47. Idro R., et al. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 4 (2005) 827-840
48. Everitt J.I., et al. Experimental Babesia bovis infection in Holstein calves. Vet. Pathol. 23 (1986) 556-562
49. O'Connor R.M., et al. Cytoadherence of Babesia bovis-infected erythrocytes to bovine brain capillary endothelial cells provides an in vitro model for sequestration. Infect. Immun. 67 (1999) 3921-3928
50. Clark I.A., et al. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthetase in falciparum malaria and sepsis in African children. Malar. J. 2 (2003) 6
51. Wright I.G., et al. Immunopathophysiology of Babesia bovis and Plasmodium falciparum infections. Parasitol. Today 4 (1988) 214-218
52. Schetters T.P., and Eling W.M. Can Babesia infections be used as a model for cerebral malaria?. Parasitol. Today 15 (1999) 492-497
53. Taylor T.E., et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10 (2004) 143-145
54. Hutchings C.L., et al. New insights into the altered adhesive and mechanical properties of red blood cells parasitized by Babesia bovis. Mol. Microbiol. 65 (2007) 1092-1105
55. Armah H., et al. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int. J. Environ. Res. Public Health 2 (2005) 123-131
56. Karunaweera N.D., et al. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3200-3203
57. Thurnham D.I., et al. The inhibition of mitochondrial respiration and oxidative phosphorylation by serum from malaria-infected animals. II. The inhibitory activity of serum ultrafiltrates from Plasmodium knowlesi-infected monkeys. Ann. Trop. Med. Parasitol. 65 (1971) 287-295
58. Clark I.A., et al. Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient. Malar. J. 5 (2006) 69
59. Molloy J.B., et al. Babesia bovis: adhesion of parasitized red blood cells to bovine umbilical vein endothelial cells in vitro does not select for virulence. Exp. Parasitol. 103 (2003) 182-184
60. Canto G.J., et al. Evaluation of cattle inoculated with Babesia bovis clones adhesive in vitro to bovine brain endothelial cells. Ann. N. Y. Acad. Sci. 1081 (2006) 397-404
61. Cooke B.M., et al. Cellular adhesive phenomena in apicomplexan parasites of red blood cells. Vet. Parasitol. 132 (2005) 273-295
62. Taylor W.R., et al. Pulmonary manifestations of malaria: recognition and management. Treat. Respir. Med. 5 (2006) 419-428
63. Dobano C., et al. Expression of merozoite surface protein markers by Plasmodium falciparum-infected erythrocytes in peripheral blood and tissues of children with fatal malaria. Infect. Immun. 75 (2007) 643-652
64. Seydel K.B., et al. The distribution and intensity of parasite sequestration in comatose Malawian children. J. Infect. Dis. 194 (2006) 208-215
65. White D.J., et al. Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors. Arch. Intern. Med. 158 (1998) 2149-2154
66. Hanafusa Y., et al. Pathogenesis of Babesia caballi infection in experimental horses. J. Vet. Med. Sci. 60 (1998) 1127-1132
67. Stone W.J., et al. Acute renal insufficiency due to falciparum malaria. Review of 42 cases. Arch. Intern. Med. 129 (1972) 620-628
68. Patarroyo J.H., et al. Description of lesions in cattle in a natural outbreak of Babesia bovis infection in Brazil. Vet. Parasitol. 11 (1982) 301-308
69. Liddell K.G., et al. Babesia divergens infections in the Mongolian gerbil: characteristics of a human strain. Parasitology 82 (1981) 205-224
70. Habela M.A., et al. Histopathological changes in sheep experimentally infected with Babesia ovis. Vet. Parasitol. 38 (1991) 1-12
71. Camacho A.T., et al. Serum protein response and renal failure in canine Babesia annae infection. Vet. Res. 36 (2005) 713-722
72. Reyers F., et al. Canine babesiosis in South Africa: more than one disease. Does this serve as a model for falciparum malaria?. Ann. Trop. Med. Parasitol. 92 (1998) 503-511
73. Zintl A., et al. Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clin. Microbiol. Rev. 16 (2003) 622-636